Streetbeat News

Stock Prices

QS

Truist Securities analyst Jordan Levy has maintained a Hold rating on QuantumScape (NYSE:QS) and increased the price target from $6 to $7.

Portfolio Pulse from Benzinga Newsdesk

November 30, 2023 | 7:18 pm

VRT

JP Morgan analyst Stephen Trent has maintained an Overweight rating on Vertiv Holdings (VRT) and increased the price target from $45 to $48.

Portfolio Pulse from Benzinga Newsdesk

November 30, 2023 | 7:16 pm

OKTA

Truist Securities analyst Joel Fishbein has maintained a Hold rating on Okta (NASDAQ:OKTA) but reduced the price target from $75 to $70.

Portfolio Pulse from Benzinga Newsdesk

November 30, 2023 | 7:16 pm

GSK

PFE

GSK plc's CEO Emma Walmsley is optimistic about the growth potential of their RSV vaccine, Arexvy, expecting sales to exceed £1 billion in its first year. The vaccine has had a strong start in the U.S. and has been approved in Europe, Japan, and other regions. Despite competition from Pfizer Inc and concerns over litigation costs related to Zantac, Walmsley believes these will not affect GSK's capital allocation strategy. GSK shares saw a 1.03% increase to $35.86.

Portfolio Pulse from Vandana Singh

November 30, 2023 | 7:15 pm

FUV

Arcimoto Inc (NASDAQ:FUV) stock is trading lower after a recent rally, with no company-specific news to justify the surge. The selloff may be due to a late filing notice from Nasdaq for its quarterly report and negative reports highlighting financial concerns, such as dwindling cash reserves. Retail traders' concerns about the market resurgence ending and profit-taking after the stock's significant appreciation could also be contributing factors. FUV shares are down 68% year-to-date but up 60% over the past week.

Portfolio Pulse from Adam Eckert

November 30, 2023 | 7:15 pm

CRM

JP Morgan analyst Mark Murphy has maintained an Overweight rating on Salesforce (NYSE:CRM) and increased the price target from $240 to $260.

Portfolio Pulse from Benzinga Newsdesk

November 30, 2023 | 7:14 pm

CBRL

IMGN

LIZI

POET

PSTG

REX

SNGX

The Nasdaq fell over 100 points while the Dow Jones gained around 300 points. Cracker Barrel's shares slid after reporting a decrease in Q1 revenues and adjusted EPS, missing consensus estimates. Soligenix, REX American Resources, and ImmunoGen saw significant share price increases, with ImmunoGen being acquired by AbbVie. Lizhi Inc., POET Technologies, and Pure Storage experienced notable declines in share prices following their respective earnings reports and public offering news. The health care sector rose, while communication services fell. Oil and gold prices dropped, while silver and copper rose. European shares closed mostly higher, and Asian markets ended on a positive note. U.S. economic data showed mixed results with a slight increase in personal spending and income, a rise in jobless claims, and a drop in pending home sales.

Portfolio Pulse from Lisa Levin

November 30, 2023 | 7:12 pm

DLTR

Dollar Tree Inc (NASDAQ:DLTR) shares rose after Q3 earnings, with analysts noting market share gains at both Dollar Tree and Family Dollar stores. Truist Securities raised the price target from $129 to $135, Goldman Sachs from $137 to $144, and BMO Capital Markets maintained a target of $170. Analysts highlighted solid sales, investments in pricing and stores, and a resilient EPS despite top-line pressures. A Family Dollar store portfolio review was also mentioned as potentially positive.

Portfolio Pulse from Priya Nigam

November 30, 2023 | 7:12 pm

FIVE

Truist Securities analyst Scot Ciccarelli has reaffirmed a Buy rating on Five Below (NASDAQ:FIVE) and increased the price target from $195 to $214.

Portfolio Pulse from Benzinga Newsdesk

November 30, 2023 | 7:10 pm

COST

Telsey Advisory Group analyst Joseph Feldman has reiterated an Outperform rating on Costco Wholesale Corporation (NASDAQ:COST), raising the price target from $600 to $625. Costco reported a solid November comp of 3.5%, with core merchandise comp at 4.4%. Traffic increased by 4.8% while the average ticket decreased by 1.3%. Costco is expected to continue as a share gainer with high membership renewal rates and is projected to generate solid EPS growth in FY24. The analyst has raised the 1Q24 EPS estimate to $3.36 from $3.32. COST shares are trading slightly lower at $587.35.

Portfolio Pulse from Nabaparna Bhattacharya

November 30, 2023 | 7:09 pm